Comparative Pharmacology
Head-to-head clinical analysis: NASCOBAL versus THIAMINE HYDROCHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NASCOBAL versus THIAMINE HYDROCHLORIDE.
NASCOBAL vs THIAMINE HYDROCHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Vitamin B12 (cyanocobalamin) is a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis.
Thiamine hydrochloride is a water-soluble vitamin that acts as a cofactor for several enzymes involved in carbohydrate metabolism, including transketolase, pyruvate dehydrogenase, and α-ketoglutarate dehydrogenase. It is essential for the decarboxylation of α-keto acids and pentose phosphate pathway activity.
1 spray (500 mcg) intranasally once weekly.
50-100 mg intravenously or intramuscularly once daily for deficiency; 100 mg intravenously for Wernicke encephalopathy (with 50-100 mg maintenance).
None Documented
None Documented
Approximately 6 days (depot effect due to slow release from injection site); for intramuscular doses, terminal elimination half-life is about 6 days due to gradual absorption
Terminal half-life: 9-18 days for whole body stores; plasma half-life: 1.5-2 hours for free thiamine.
Primarily renal (60-80% as unchanged drug), biliary/fecal (5-10%)
Renal: 40-50% as unchanged drug; metabolites: thiamine pyrophosphate, thiamine monophosphate. Fecal: minimal (<5%).
Category C
Category C
Vitamin
Vitamin